Zhejiang Medicine Co Ltd Cash Flow Reinvestment Rate
Zhejiang Medicine Co Ltd cash flow reinvestment rate. Zhejiang Medicine Co Ltd (600216) has a Cash Flow Reinvestment Rate of 0.12x as of September 2025, reinvesting CN¥80.03 Million (capex CN¥80.03 Million ) from operating cash flow of CN¥690.77 Million. Explore Zhejiang Medicine Co Ltd (600216) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Medicine Co Ltd (1998–2025)
Cash flow reinvestment rate of Zhejiang Medicine Co Ltd from 1998 to 2025. Historical reinvestment intensity for Zhejiang Medicine Co Ltd across 27 annual periods. Explore Zhejiang Medicine Co Ltd (600216) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Medicine Co Ltd Cash Flow Reinvestment Rate by Year (1998–2025)
Zhejiang Medicine Co Ltd cash flow reinvestment rate by year from 1998 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Medicine Co Ltd. For the full cash flow conversion analysis, see 600216 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | CN¥453.57 Million | CN¥1.89 Billion | CN¥446.47 Million | ▼ -58.8% |
| 2024 | 0.58x | CN¥714.46 Million | CN¥1.22 Billion | CN¥689.14 Million | ▼ -71.8% |
| 2023 | 2.07x | CN¥1.32 Billion | CN¥634.31 Million | CN¥796.87 Million | ▼ -44.6% |
| 2022 | 3.74x | CN¥1.95 Billion | CN¥520.60 Million | CN¥975.99 Million | ▲ +334.4% |
| 2021 | 0.86x | CN¥978.73 Million | CN¥1.14 Billion | CN¥939.60 Million | ▲ +29.5% |
| 2020 | 0.66x | CN¥835.67 Million | CN¥1.26 Billion | CN¥535.35 Million | ▼ -52.8% |
| 2019 | 1.41x | CN¥630.40 Million | CN¥447.25 Million | CN¥573.63 Million | ▲ +79.9% |
| 2018 | 0.78x | CN¥454.26 Million | CN¥579.91 Million | CN¥439.30 Million | ▼ -53.7% |
| 2017 | 1.69x | CN¥851.21 Million | CN¥503.47 Million | CN¥569.99 Million | ▲ +48.8% |
| 2016 | 1.14x | CN¥382.01 Million | CN¥336.14 Million | CN¥381.76 Million | ▼ -87.8% |
| 2015 | 9.29x | CN¥989.93 Million | CN¥106.54 Million | CN¥724.96 Million | ▲ +415.2% |
| 2014 | 1.80x | CN¥991.76 Million | CN¥549.90 Million | CN¥991.76 Million | ▼ -0.5% |
| 2013 | 1.81x | CN¥1.19 Billion | CN¥655.09 Million | CN¥1.19 Billion | ▲ +54.8% |
| 2012 | 1.17x | CN¥945.50 Million | CN¥807.49 Million | CN¥945.50 Million | ▲ +210.2% |
| 2011 | 0.38x | CN¥344.58 Million | CN¥912.75 Million | CN¥344.58 Million | ▲ +240.6% |
| 2010 | 0.11x | CN¥145.90 Million | CN¥1.32 Billion | CN¥145.90 Million | ▲ +6.0% |
| 2009 | 0.10x | CN¥153.13 Million | CN¥1.47 Billion | CN¥153.13 Million | ▼ -3.7% |
| 2008 | 0.11x | CN¥130.27 Million | CN¥1.20 Billion | CN¥130.27 Million | ▼ -83.9% |
| 2007 | 0.67x | CN¥153.37 Million | CN¥227.67 Million | CN¥153.37 Million | ▼ -54.3% |
| 2006 | 1.47x | CN¥249.99 Million | CN¥169.51 Million | CN¥249.99 Million | ▼ -89.2% |
| 2005 | 13.60x | CN¥341.93 Million | CN¥25.14 Million | CN¥341.93 Million | ▲ +910.5% |
| 2004 | 1.35x | CN¥144.80 Million | CN¥107.60 Million | CN¥144.80 Million | ▼ -32.2% |
| 2003 | 1.98x | CN¥131.37 Million | CN¥66.20 Million | CN¥131.37 Million | ▼ -78.5% |
| 2002 | 9.25x | CN¥213.81 Million | CN¥23.13 Million | CN¥213.81 Million | ▲ +654.2% |
| 2001 | 1.23x | CN¥120.44 Million | CN¥98.25 Million | CN¥120.44 Million | ▼ -89.5% |
| 2000 | 11.69x | CN¥123.69 Million | CN¥10.58 Million | CN¥123.69 Million | ▲ +435.0% |
| 1998 | 2.18x | CN¥126.08 Million | CN¥57.72 Million | CN¥126.08 Million | — |